[go: up one dir, main page]

AU2001269766A1 - Compositions and methods for the therapy and diagnosis of colon cancer - Google Patents

Compositions and methods for the therapy and diagnosis of colon cancer

Info

Publication number
AU2001269766A1
AU2001269766A1 AU2001269766A AU6976601A AU2001269766A1 AU 2001269766 A1 AU2001269766 A1 AU 2001269766A1 AU 2001269766 A AU2001269766 A AU 2001269766A AU 6976601 A AU6976601 A AU 6976601A AU 2001269766 A1 AU2001269766 A1 AU 2001269766A1
Authority
AU
Australia
Prior art keywords
diagnosis
therapy
compositions
methods
colon cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269766A
Inventor
Jonathan D. Clapper
William T. Hepler
Yuqiu Jiang
Heather Secrist
Aijun Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001269766A1 publication Critical patent/AU2001269766A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001269766A 2000-06-09 2001-06-08 Compositions and methods for the therapy and diagnosis of colon cancer Abandoned AU2001269766A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US21082100P 2000-06-09 2000-06-09
US60/210,821 2000-06-09
US25657100P 2000-12-18 2000-12-18
US60/256,571 2000-12-18
US29024001P 2001-05-10 2001-05-10
US60/290,240 2001-05-10
PCT/US2001/018577 WO2001096390A2 (en) 2000-06-09 2001-06-08 Compositions and methods for the therapy and diagnosis of colon cancer

Publications (1)

Publication Number Publication Date
AU2001269766A1 true AU2001269766A1 (en) 2001-12-24

Family

ID=27395561

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269766A Abandoned AU2001269766A1 (en) 2000-06-09 2001-06-08 Compositions and methods for the therapy and diagnosis of colon cancer

Country Status (6)

Country Link
US (1) US20020040127A1 (en)
EP (1) EP1287029A2 (en)
JP (1) JP2004512023A (en)
AU (1) AU2001269766A1 (en)
CA (1) CA2411278A1 (en)
WO (1) WO2001096390A2 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759508B2 (en) 2000-09-01 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
HUP0500345A2 (en) * 2000-03-29 2005-07-28 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
EP1415987B1 (en) * 2000-10-20 2007-02-28 Eisai R&D Management Co., Ltd. Nitrogenous aromatic ring compounds as anti cancer agents
AU2002318112B2 (en) 2001-04-10 2007-12-06 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
AU2002311909A1 (en) * 2001-05-11 2002-11-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2003043565A2 (en) * 2001-09-24 2003-05-30 University Of Aarhus Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
WO2003104454A1 (en) * 2002-06-06 2003-12-18 山之内製薬株式会社 Novel oxidase
EP1520046A2 (en) * 2002-06-27 2005-04-06 Aarhus University Disease risk estimating method using sequence polymorphisms in a specific region of chromosome 19
WO2004057336A2 (en) 2002-12-20 2004-07-08 Roche Diagnostics Gmbh Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
ATE508747T1 (en) * 2003-03-10 2011-05-15 Eisai R&D Man Co Ltd C-KIT KINASE INHIBITORS
EP1607404A4 (en) * 2003-03-14 2008-01-23 Taisho Pharmaceutical Co Ltd MONOCLONAL ANTIBODY AND HYBRIDOMA PRODUCING THE SAME
JPWO2005021739A1 (en) * 2003-09-01 2006-10-26 株式会社クレハ Antibody against Nox1 polypeptide, cancer diagnostic method using Nox1 gene, and screening method for cancer growth inhibitory substance
US20090252721A1 (en) * 2003-09-18 2009-10-08 Thomas Buschmann Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
WO2005044788A1 (en) * 2003-11-11 2005-05-19 Eisai Co., Ltd. Urea derivative and process for producing the same
US7927313B2 (en) * 2004-05-27 2011-04-19 Baxter International Inc. Medical device configuration based on recognition of identification information
AU2005283422C1 (en) 2004-09-17 2017-02-02 Eisai R & D Management Co., Ltd. Medicinal composition
EP1925941B1 (en) * 2005-08-01 2012-11-28 Eisai R&D Management Co., Ltd. Method for prediction of the efficacy of vascularization inhibitor
EP2281901B1 (en) * 2005-08-02 2013-11-27 Eisai R&D Management Co., Ltd. Anti-tumour pharmaceutical composition with angiogenesis inhibitors
CN101277720A (en) * 2005-09-01 2008-10-01 卫材R&D管理有限公司 Process for producing pharmaceutical composition with improved disintegrability
CA2627598C (en) 2005-11-07 2013-06-25 Eisai R & D Management Co., Ltd. Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
WO2007061127A1 (en) * 2005-11-22 2007-05-31 Eisai R & D Management Co., Ltd. Anti-tumor agent for multiple myeloma
WO2007136103A1 (en) * 2006-05-18 2007-11-29 Eisai R & D Management Co., Ltd. Antitumor agent for thyroid cancer
EP2044939A1 (en) * 2006-06-29 2009-04-08 Eisai R&D Management Co., Ltd. Therapeutic agent for liver fibrosis
WO2008026748A1 (en) * 2006-08-28 2008-03-06 Eisai R & D Management Co., Ltd. Antitumor agent for undifferentiated gastric cancer
EP2119707B1 (en) * 2007-01-29 2015-01-14 Eisai R&D Management Co., Ltd. Composition for treatment of undifferentiated-type of gastric cancer
CN103360466B (en) * 2007-07-27 2016-08-03 伊玛提克斯生物技术有限公司 Antitumor related peptides and relevant anti-cancer vaccine compositions
WO2009015842A2 (en) * 2007-07-27 2009-02-05 Immatics Biotechnologies Gmbh Novel immunogenic epitopes for immunotherapy
CA2704000C (en) 2007-11-09 2016-12-13 Eisai R&D Management Co., Ltd. Combination of anti-angiogenic substance and anti-tumor platinum complex
KR101506062B1 (en) * 2008-01-29 2015-03-25 에자이 알앤드디 매니지먼트 가부시키가이샤 Combined use of angiogenesis inhibitor and taxane
KR101051435B1 (en) * 2008-10-22 2011-07-22 한국생명공학연구원 Colorectal cancer diagnostic kit using colorectal cancer-related markers and colorectal cancer diagnostic method using the same
ES2564797T3 (en) 2009-08-19 2016-03-29 Eisai R&D Management Co., Ltd. Pharmaceutical composition containing a quinoline derivative
RU2560683C2 (en) 2010-06-25 2015-08-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Anticancer agent involving combinations of kinase inhibitory compounds
MX2013009931A (en) 2011-04-18 2013-10-01 Eisai R&D Man Co Ltd Therapeutic agent for tumor.
ES2705950T3 (en) 2011-06-03 2019-03-27 Eisai R&D Man Co Ltd Biomarkers to predict and assess the responsiveness of subjects with thyroid and kidney cancer to lenvatinib compounds
WO2014098176A1 (en) 2012-12-21 2014-06-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 Amorphous form of quinoline derivative, and method for producing same
RU2658601C2 (en) 2013-05-14 2018-06-21 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
ES2926687T3 (en) 2014-08-28 2022-10-27 Eisai R&D Man Co Ltd Highly pure quinoline derivative and method for its production
RS65049B1 (en) 2015-02-25 2024-02-29 Eisai R&D Man Co Ltd Method for suppressing bitterness of quinoline derivative
AU2015384801B2 (en) 2015-03-04 2022-01-06 Eisai R&D Management Co., Ltd. Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer
CA2988707C (en) 2015-06-16 2023-10-10 Eisai R&D Management Co., Ltd. Combination of cbp/catenin inhibitor and immune checkpoint inhibitor for treating cancer
ES2887426T3 (en) 2015-08-20 2021-12-22 Eisai R&D Man Co Ltd Lenvatinib combined with etoposide and ifosfamide for use in treating a tumor
JP6786074B2 (en) * 2016-04-04 2020-11-18 国立研究開発法人医薬基盤・健康・栄養研究所 Exosome-targeted DNA vaccine
JP6581320B2 (en) 2017-02-08 2019-09-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 Pharmaceutical composition for tumor treatment
RU2019134940A (en) 2017-05-16 2021-06-16 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. TREATMENT OF HEPATOCELLULAR CARCINOMA

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2118760C (en) * 1993-04-21 2004-06-22 William Jeffrey Allard Diagnosis and monitoring of colon cancer patients by measurement of nca 50/90 in blood
WO1999060161A1 (en) * 1998-05-21 1999-11-25 Diadexus Llc A novel method of diagnosing, monitoring, and staging colon cancer
IL139988A0 (en) * 1998-06-01 2002-02-10 Urogenesys Inc Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
WO2000028031A2 (en) * 1998-11-10 2000-05-18 Emory University Mitogenic regulators
WO2001022920A2 (en) * 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
AU2608201A (en) * 1999-12-30 2001-07-16 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU2001241415A1 (en) * 2000-01-31 2001-08-07 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2001073027A2 (en) * 2000-03-24 2001-10-04 Corixa Corporation Compositions and methods for therapy and diagnosis of colon cancer
JP2004512022A (en) * 2000-06-09 2004-04-22 コリクサ　コーポレイション Compositions and methods for treatment and diagnosis of colon cancer
EP1705487A3 (en) * 2000-07-17 2008-03-19 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating colon cancer
EP1307556A2 (en) * 2000-08-03 2003-05-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer

Also Published As

Publication number Publication date
WO2001096390A3 (en) 2002-12-27
CA2411278A1 (en) 2001-12-20
EP1287029A2 (en) 2003-03-05
WO2001096390A2 (en) 2001-12-20
US20020040127A1 (en) 2002-04-04
JP2004512023A (en) 2004-04-22

Similar Documents

Publication Publication Date Title
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002311909A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002254482A1 (en) Compositions and methods for the therapy and diagnosis of kidney cancer
AU2001252945A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU3483001A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001266790A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002253899A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer